Implementing Quality Assurance Programs in MultiGroup Practices for Treating Hypercholesterolemia in Patients With Coronary Artery Disease

This publication has 20 references indexed in Scilit:

• Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery Disease
  The American Journal of Cardiology, 1996
• Improving physicians' preventive health care behavior through peer review and financial incentives
  Archives of Family Medicine, 1995
• Getting cardiologists interested in lipids
  The American Journal of Cardiology, 1993
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study)
  The American Journal of Cardiology, 1992
• Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.
  Circulation, 1991
• Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
  Published by American Medical Association (AMA) ,1991
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid
  Acta Medica Scandinavica, 1988
• Clofibrate and Niacin in Coronary Heart Disease
  JAMA, 1975